Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Daily American Samoa.
Press releases published on June 26, 2025

Extendicare Announces Renewal of Normal Course Issuer Bid
MARKHAM, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under …

Teva Releases Q2 2025 Aide Memoire
TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2025 Aide Memoire is available on the “Investors” page on its website. Q2 2025 Aide Memoire Teva has prepared this …

Lifeward Announces Closing of $2.6 Million Public Offering
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …

Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising
Singapore, June 26, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that Cathay Securities, Inc., as the representative of the several underwriters of the Company’s initial public offering, has granted its …

Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2025 financial and operating results on Friday, August 1, 2025, before the U.S. financial markets open. …

Achieve Life Sciences Announces Proposed Underwritten Public Offering
SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
WAYNE, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it will provide a …

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, June 26, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

CorMedix Inc. Announces Proposed Public Offering of Common Stock
BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it intends …

INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
Company to host a conference call to discuss results at 8:00am EDT on June 30, 2025 Boca Raton, Florida, June 26, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, will host a …

America's Blood Centers Honors HOSA-Future Health Professionals Lifesaving Impact at 2025 International Leadership Conference
Washington, DC, June 26, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, honored HOSA-Future Health Professionals chapters …

EVA Pharma and BioPharma Town - Qiantang District, Hangzhou Sign a Strategic Cooperation Agreement
HANGZHOU, China and CAIRO, June 26, 2025 (GLOBE NEWSWIRE) -- EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, has signed a cooperation agreement with the Chaming Qiantang …

EVA制药与杭州市钱塘区签署战略合作协议
杭州,开罗, June 27, 2025 (GLOBE NEWSWIRE) -- EVA制药公司,中东和非洲地区增长最快的医疗保健组织之一,与杭州美丽云城管理办公室(Chaming Qiantang Management Office)签署了一项合作协议,以加强其全球战略扩展,并致力于在中国的创新、本地化和全球合作。 EVA …

Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company
BEDFORD, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, announced the launch of its new corporate branding and website today, marking …

PetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ET
MINNEAPOLIS, MN, US, June 26, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, will hold a conference call on …

Autism Spectrum Disorder Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 20+ Companies and 22+ Therapies | DelveInsight
New York, USA, June 26, 2025 (GLOBE NEWSWIRE) -- Autism Spectrum Disorder Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 20+ Companies and 22+ Therapies | DelveInsight Autism Spectrum Disorder is defined as a group of developmental …

Global Medical Drones Market Gearing Up for Outstanding Expansion at a CAGR of ~17% by 2032 | DelveInsight
New York, USA, June 26, 2025 (GLOBE NEWSWIRE) -- Global Medical Drones Market Gearing Up for Outstanding Expansion at a CAGR of ~17% by 2032 | DelveInsight Several key factors are fueling the rising demand for medical drones, creating a supportive …

Press release: Transparency Notification from Shareholders
Transparency Notification from Shareholders Ghent, Belgium – 26 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and …

Iona University Announces New Master’s Degree in Healthcare Leadership & Innovation
New Rochelle …

STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation
www.stentit.com Watch the video Click the White paper STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation EINDHOVEN, The Netherlands – June 26, 2025 – STENTiT, a pioneering …